LoftyRock Investment
Overview
LoftyRock Investment is a venture capital firm based in Seoul, South Korea, established in 2021. The firm focuses on early-stage investments in biotechnology and technology sectors, aiming to support companies with disruptive innovations. Their investment strategy emphasizes opportunities created by technological breakthroughs and convergence, particularly in areas such as biotechnology, genetics, delivery services, and therapeutics. The firm's portfolio includes investments in companies like GenEdit Inc., a biotechnology firm specializing in genome editing tools, and Galux, a company focused on molecular design technology for drug discovery. These investments reflect LoftyRock's commitment to advancing healthcare and technology through strategic funding. LoftyRock Investment operates with a team of professionals dedicated to identifying and nurturing high-potential startups. Their approach combines financial support with strategic guidance to foster growth and innovation in their portfolio companies.
Investment Focus
- Innovative technology solutions
- Strong management teams
- Scalable business models
Portfolio Companies
Reach LoftyRock Investment directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about LoftyRock Investment
What sectors does LoftyRock Investment invest in?
LoftyRock Investment invests in Biotechnology, Therapeutics, Delivery Service and Genetics, and is based in Seoul, South Korea. LoftyRock Investment is listed as a venture capital in the ConnectSafely investor database.
Which regions does LoftyRock Investment invest in?
LoftyRock Investment invests across United States and South Korea.
What companies has LoftyRock Investment invested in?
LoftyRock Investment's portfolio includes GenEdit Inc. and Galux.
Last updated · Source: ConnectSafely investor database
